S
03681
SinoMab BioScience
1.180
0.0000.00%Closed16:09 06/05 HKT
OPEN/PREV CLOSE1.070/1.080
TODAY RANGE1.060-1.370
VOL16.78M
MARKET CAP1.90B
52 WEEK RANGE1.010-3.760
AVG VOL (3M)3.78M
% TURNOVER1.21%
TURNOVER19.05M
P/E (TTM)-16.348
% RANGE28.70%
EPS(TTM)-0.084
P/E(FORWARD)3.404
P/B3.379
BVPS0.406
DIVIDEND--
P/S1,481.250
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.90B
SHARES OUTSTANDING1.39B
NEXT EARNINGS--
FREE FLOAT1.39B
LOT SIZE300
EX-DATE--
News
Press Releases
Financial Reports
Profile
PUBT·04/27 09:50
SinoMab BioScience releases 2025 ESG report
PUBT·04/27 09:36
SinoMab BioScience announces annual general meeting
PUBT·04/27 09:32
SinoMab BioScience publishes 2025 annual report
Reuters·03/31 20:59
SinoMab BioScience says non-executive directors Chen, Dong resign
Reuters·03/31 20:58
SinoMab BioScience files list of directors with Hong Kong Stock Exchange
Reuters·03/24 11:50
SinoMab grants 11,574,840 share options at HKD 1.94 per share
Reuters·03/10 11:55
SinoMab BioScience to Hold Board Meeting to Approve Full-Year Results
Reuters·02/24 13:58
China NMPA approves SinoMab SM17 IND for inflammatory bowel disease
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.